Ispire Q2 Revenue Halves to $20.3M as Net Loss Narrows to $6.6M
Ispire Technology’s fiscal Q2 revenue plunged 51% to $20.3 million while net loss narrowed to $6.6 million from $8.0 million a year earlier. Net accounts receivable fell 19.5% to $37.9 million and cash on hand stood at $17.6 million as of December 31, 2025.
1. Q2 Financial Performance
Ispire reported Q2 revenue of $20.3 million, down from $41.8 million in the prior-year period, driven by its shift away from lower-quality cannabis customers. Gross profit declined to $3.5 million with a 17.1% margin, while operating expenses fell 32% to $10.3 million, narrowing the net loss to $6.6 million from $8.0 million.
2. Balance Sheet Highlights
The company ended the quarter with $17.6 million in cash and working capital of $3.5 million. Net accounts receivable decreased 19.5% to $37.9 million from $47.0 million at June 30, 2025, reflecting focused collections and customer quality rationalization.
3. Manufacturing and Technology Initiatives
Ispire is ramping production at its new Malaysian facility to support expected top-line recovery and growing demand. Momentum is building behind its G-Mesh vaping technology, with large nicotine manufacturers engaged in potential licensing and partnership discussions.
4. Regulatory and Market Tailwinds
Through its IKE Tech joint venture, Ispire is advancing age-gating solutions in Europe, Southeast Asia and the Middle East. Enhanced FDA enforcement on unauthorized flavored e-cigarettes and requirements for age-gating technology in the U.S. present a potential boost for Ispire’s compliant product offerings.